Drilon wants PhilHealth revamp over alleged COVID-19 test overpricing

Senate Minority Leader Franklin Drilon is calling for a revamp of the Philippine Health Insurance Corporation (PhilHealth) due to an alleged overpricing scandal involving its COVID-19 testing packages.

Drilon believes a specific group within PhilHealth is responsible for setting unreasonable prices for these test packages, suggesting a network with hospitals and service providers.

He pointed out that this is not the first time PhilHealth has faced irregularities, citing the previous "ghost dialysis" controversy.

Drilon urged PhilHealth to lower the cost of its COVID-19 test packages to P3,500, aligning with the rate agreed upon with the Philippine Red Cross.

He stated that there is prima facie evidence of an anomaly, even if the intention to overprice was not proven.

Drilon emphasized the need for reorganization within PhilHealth and for corruption cases to be filed if found.

He also highlighted the crucial role of media in guarding the investigation to ensure it is not forgotten.

Furthermore, Drilon suggested that PhilHealth president and CEO Ricardo Morales and Health Secretary Francisco Duque III could be held liable for negligence in relation to the alleged overpricing.

Topics in this story

Explore more stories about these topics.

🤖

This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.

News Sources

See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.